Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Dev Biol. 2021 Feb 16;473:119–129. doi: 10.1016/j.ydbio.2021.02.005

Figure 6. SHF markers of the arterial pole are reduced in RA-deficient embryos.

Figure 6.

(A,B) ISH for mef2cb at 30 hpf in DMSO- and DEAB-treated embryos. (C,D) ISH for ltbp3 at 30 hpf in DMSO- and DEAB-treated embryos. Number of embryos examined per condition: mef2cb DMSO-treated n=31; DEAB-treated n=18; for ltbp3 DMSO-treated n=18; DEAB-treated n=16. Views are dorsal with anterior up. Arrows indicate the length of expression at the arterial poles.